Sean Laaman
Stock Analyst at Morgan Stanley
(4.67)
# 822
Out of 5,060 analysts
602
Total ratings
58.6%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Rated: Buy | $405 → $425 | $369.06 | +15.16% | 13 | Oct 16, 2026 | |
| RXRX Recursion Pharmaceuticals | Rated: Hold | $5.3 → $5.9 | $3.47 | +70.27% | 6 | Oct 16, 2026 | |
| ALEC Alector | Reiterated: Sell | $3 | $1.84 | +63.04% | 8 | Oct 14, 2026 | |
| ASND Ascendis Pharma | Rated: Buy | $273 | $225.24 | +21.20% | 1 | Oct 12, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Hold | $17 | $7.08 | +140.11% | 11 | Oct 12, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,250 → $1,140 | $819.14 | +39.17% | 14 | Oct 9, 2026 | |
| ELVN Enliven Therapeutics | Initiated Coverage: Buy | $70 | $37.32 | +87.57% | 1 | Oct 5, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Hold | $251 → $247 | $157.14 | +57.18% | 11 | Sep 25, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $124 | $54.68 | +126.77% | 11 | Sep 16, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $12.91 | +132.38% | 11 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $182 → $183 | $135.77 | +34.79% | 22 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 | $177.96 | +43.29% | 1 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $283 → $322 | $210.23 | +53.17% | 18 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 → $28 | $19.12 | +46.44% | 14 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 | $8.25 | +21.21% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $2.82 | +538.30% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $59.87 | +55.35% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $7.42 | +331.27% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $13.39 | +56.83% | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $12.09 | +81.97% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 → $90 | $56.84 | +58.34% | 13 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $7.70 | +172.73% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $97 | $66.39 | +46.11% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $17.61 | +127.14% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $105 | $121.84 | -13.82% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $43 | $29.40 | +46.26% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 | $62.23 | -14.83% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $22.60 | -24.78% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.30 | $2.85 | n/a | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $9.37 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.80 → $3.95 | $4.74 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $238.97 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.70 | $34.35 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310.00 | $192.20 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.60 → $31.65 | $18.57 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25.38 → $24.14 | $46.17 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26.75 → $28.76 | $48.61 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $276.00 → $256.00 | $131.13 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.30 | $0.38 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.15 → $7.35 | $6.52 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.45 → $1.65 | $0.72 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47.99 → $46.76 | $20.40 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53.60 → $51.60 | $55.55 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.70 → $2.75 | $2.11 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.82 | n/a | 2 | Aug 24, 2021 |
BeOne Medicines AG
Oct 16, 2026
Rated: Buy
Price Target: $405 → $425
Current: $369.06
Upside: +15.16%
Recursion Pharmaceuticals
Oct 16, 2026
Rated: Hold
Price Target: $5.3 → $5.9
Current: $3.47
Upside: +70.27%
Alector
Oct 14, 2026
Reiterated: Sell
Price Target: $3
Current: $1.84
Upside: +63.04%
Ascendis Pharma
Oct 12, 2026
Rated: Buy
Price Target: $273
Current: $225.24
Upside: +21.20%
Contineum Therapeutics
Oct 12, 2026
Reiterated: Hold
Price Target: $17
Current: $7.08
Upside: +140.11%
argenx SE
Oct 9, 2026
Reiterated: Buy
Price Target: $1,250 → $1,140
Current: $819.14
Upside: +39.17%
Enliven Therapeutics
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $37.32
Upside: +87.57%
Axsome Therapeutics
Sep 25, 2026
Reiterated: Hold
Price Target: $251 → $247
Current: $157.14
Upside: +57.18%
BioMarin Pharmaceutical
Sep 16, 2026
Rated: Buy
Price Target: $124
Current: $54.68
Upside: +126.77%
Cullinan Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $12.91
Upside: +132.38%
Sep 11, 2026
Rated: Hold
Price Target: $182 → $183
Current: $135.77
Upside: +34.79%
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $255
Current: $177.96
Upside: +43.29%
Aug 26, 2026
Rated: Buy
Price Target: $283 → $322
Current: $210.23
Upside: +53.17%
Aug 25, 2026
Rated: Hold
Price Target: $27 → $28
Current: $19.12
Upside: +46.44%
Aug 17, 2026
Rated: Hold
Price Target: $10
Current: $8.25
Upside: +21.21%
Aug 17, 2026
Rated: Buy
Price Target: $18
Current: $2.82
Upside: +538.30%
Aug 17, 2026
Rated: Buy
Price Target: $93
Current: $59.87
Upside: +55.35%
Aug 17, 2026
Rated: Buy
Price Target: $32
Current: $7.42
Upside: +331.27%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $13.39
Upside: +56.83%
Aug 17, 2026
Rated: Buy
Price Target: $22
Current: $12.09
Upside: +81.97%
Aug 17, 2026
Rated: Buy
Price Target: $85 → $90
Current: $56.84
Upside: +58.34%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $7.70
Upside: +172.73%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $97
Current: $66.39
Upside: +46.11%
Aug 7, 2026
Rated: Buy
Price Target: $36 → $40
Current: $17.61
Upside: +127.14%
Aug 7, 2026
Rated: Buy
Price Target: $93 → $105
Current: $121.84
Upside: -13.82%
Aug 7, 2026
Reiterated: Hold
Price Target: $40 → $43
Current: $29.40
Upside: +46.26%
Aug 6, 2026
Reiterated: Hold
Price Target: $53
Current: $62.23
Upside: -14.83%
May 14, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $22.60
Upside: -24.78%
Aug 28, 2025
Reiterated: Buy
Price Target: $3.30
Current: $2.85
Upside: n/a
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $9.37
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: $3.80 → $3.95
Current: $4.74
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $238.97
Upside: n/a
Jun 24, 2024
Reiterated: Buy
Price Target: $33.70
Current: $34.35
Upside: n/a
Jun 12, 2024
Reiterated: Buy
Price Target: $310.00
Current: $192.20
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $33.60 → $31.65
Current: $18.57
Upside: n/a
Apr 9, 2024
Reiterated: Hold
Price Target: $25.38 → $24.14
Current: $46.17
Upside: n/a
Mar 22, 2024
Reiterated: Hold
Price Target: $26.75 → $28.76
Current: $48.61
Upside: n/a
Mar 21, 2024
Reiterated: Sell
Price Target: $276.00 → $256.00
Current: $131.13
Upside: n/a
Feb 28, 2024
Reiterated: Sell
Price Target: $1.30
Current: $0.38
Upside: n/a
Feb 27, 2024
Reiterated: Hold
Price Target: $8.15 → $7.35
Current: $6.52
Upside: n/a
Feb 26, 2024
Reiterated: Buy
Price Target: $1.45 → $1.65
Current: $0.72
Upside: n/a
Jan 12, 2024
Reiterated: Buy
Price Target: $47.99 → $46.76
Current: $20.40
Upside: n/a
Nov 28, 2023
Reiterated: Hold
Price Target: $53.60 → $51.60
Current: $55.55
Upside: n/a
Aug 28, 2023
Reiterated: Sell
Price Target: $2.70 → $2.75
Current: $2.11
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $12.82
Upside: n/a